C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors

Int J Cancer. 2001 Nov;94(4):480-4. doi: 10.1002/ijc.1512.

Abstract

Mouse coding region determinant-binding (mCRD-BP) and human IGF-II mRNA-binding 1 (hIMP-1) proteins are orthologous mRNA-binding proteins that recognize c-myc and IGF-II mRNA, respectively, and regulate their expression posttranscriptionally. Here, we confirm that human CRD-BP/IMP-1 binds to c-myc mRNA and that it is predominantly expressed in fetal tissues. Moreover, hCRD-BP/IMP-1 expression was detected in cell lines of neoplastic origin and in selected primary tumors. In a series of 33 malignant and 10 benign mesenchymal tumors, 73% and 40%, respectively, were found to express hCRD-BP/IMP-1. In particular, expression was significant in 14 Ewing's sarcomas, all of which were positive. The data suggest that hCRD-BP/IMP-1 plays a role in abnormal cell proliferation in mesenchymal tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs
  • Animals
  • Base Sequence
  • Cell Division
  • Chromosome Mapping
  • DNA, Complementary / metabolism
  • Humans
  • Mesenchymoma / metabolism*
  • Mice
  • Molecular Sequence Data
  • Protein Binding
  • Proto-Oncogene Proteins c-myc / metabolism
  • RNA / metabolism
  • RNA, Messenger / metabolism
  • RNA-Binding Proteins / biosynthesis*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sarcoma, Ewing / metabolism
  • Tissue Distribution
  • Tumor Cells, Cultured

Substances

  • DNA, Complementary
  • IGF2BP1 protein, human
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • RNA-Binding Proteins
  • RNA